Literature DB >> 24309541

pH-sensitive nano-systems for drug delivery in cancer therapy.

Juan Liu1, Yuran Huang1, Anil Kumar2, Aaron Tan3, Shubin Jin1, Anbu Mozhi1, Xing-Jie Liang4.   

Abstract

Nanotechnology has been widely used in the development of new strategies for drug delivery and cancer therapy. Compared to traditional drug delivery systems, nano-based drug delivery system have greater potential in a variety of areas, such as multiple targeting functionalization, in vivo imaging, combined drug delivery, extended circulation time, and systemic control release. Nano-systems incorporating stimulus-responsive materials have remarkable properties which allow them to bypass biological barriers and achieve targeted intracellular drug delivery. As a result of the active metabolism of tumor cells, the tumor microenvironment (TME) is highly acidic compared to normal tissues. pH-Sensitive nano-systems have now been developed in which drug release is specifically triggered by the acidic tumor environment. Studies have demonstrated that novel pH-sensitive drug delivery systems are capable of improving the efficiency of cancer treatment. A number of these have been translated from bench to clinical application and have been approved by the Food and Drug Administration (FDA) for treatment of various cancerous diseases. Herein, this review mainly focuses on pH-sensitive nano-systems, including advances in drug delivery, mechanisms of drug release, and possible improvements in drug absorption, with the emphasis on recent research in this field. With deeper understanding of the difference between normal and tumor tissues, it might be possible to design ever more promising pH-responsive nano-systems for drug delivery and cancer therapy in the near future. Crown
Copyright © 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Controlled drug release; Drug delivery system; Nanomedicine; pH-Sensitive nanoparticles

Mesh:

Substances:

Year:  2013        PMID: 24309541     DOI: 10.1016/j.biotechadv.2013.11.009

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  139 in total

1.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

Review 2.  Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.

Authors:  Samuel S Linton; Samantha G Sherwood; Kelly C Drews; Mark Kester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-07-07

Review 3.  Extracellularly activatable nanocarriers for drug delivery to tumors.

Authors:  Sara A Abouelmagd; Hyesun Hyun; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2014-06-20       Impact factor: 6.648

Review 4.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

5.  Substituent Effects on the pH Sensitivity of Acetals and Ketals and Their Correlation with Encapsulation Stability in Polymeric Nanogels.

Authors:  Bin Liu; S Thayumanavan
Journal:  J Am Chem Soc       Date:  2017-02-02       Impact factor: 15.419

Review 6.  Implantable Sensors for Regenerative Medicine.

Authors:  Brett S Klosterhoff; Melissa Tsang; Didi She; Keat Ghee Ong; Mark G Allen; Nick J Willett; Robert E Guldberg
Journal:  J Biomech Eng       Date:  2017-02-01       Impact factor: 2.097

7.  Electrostatics-Driven Inflation of Elastic Icosahedral Shells as a Model for Swelling of Viruses.

Authors:  Anže Lošdorfer Božič; Antonio Šiber
Journal:  Biophys J       Date:  2018-08-07       Impact factor: 4.033

Review 8.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

9.  Reversibly extracellular pH controlled cellular uptake and photothermal therapy by PEGylated mixed-charge gold nanostars.

Authors:  Shouju Wang; Zhaogang Teng; Peng Huang; Dingbin Liu; Ying Liu; Ying Tian; Jing Sun; Yanjun Li; Huangxian Ju; Xiaoyuan Chen; Guangming Lu
Journal:  Small       Date:  2015-01-07       Impact factor: 13.281

Review 10.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.